The mechanism
Why Your Body Absorbs Food Better Than Pills: The Food Matrix, Explained
By Dr. Raj Dhadwal
A friend once described the moment plainly: he found an undissolved multivitamin tablet in the toilet bowl, hours after swallowing it, still legibly stamped with the manufacturer's logo. It had traveled the entire length of his digestive tract and come out the other side essentially unchanged. He had paid for the tablet, swallowed the tablet, and absorbed, by any reasonable estimate, very little of what the label promised. This is not a rare story. Pharmacists have a name for it, "ghost tablets," and gastroenterologists occasionally publish case reports and letters describing capsule or tablet shells recovered intact in stool, especially in patients on extended-release formulations, patients with reduced stomach acid, or patients simply eating in a hurry with a large glass of water and nothing else in their stomach. The tablet did not fail because the person did something wrong. It failed because a pill and a nutrient are not the same problem, and the industry that makes pills has spent a century optimizing for shelf life, dosing precision, and manufacturing cost, not necessarily for what actually crosses into a bloodstream.
This article is about that gap, formally called bioavailability, and specifically about why the physical form nutrients arrive in changes how much of them a body actually gets to use. It is a deep dive into the food matrix: what it is, why fat-soluble nutrients like carotenoids depend on dietary fat to be absorbed at all, why compounds that occur together in a plant seem to help each other get used, why an isolated high dose of a single nutrient can behave completely differently in the body than the same nutrient eaten as part of a whole food, what "first-pass metabolism" means for anything you swallow, and what all of this should change about how a shopper picks between an isolate capsule, a liposomal formula, a gummy, a powder, and a whole-food puree. This is a mechanism article, not a manufacturing-and-regulation article. If you are looking for the food-versus-supplement definitional and regulatory history, including the specific 1994 and 2004 legal frameworks that formally split whole food from dietary supplement as legal categories, that ground has already been covered elsewhere in the Journal and is not repeated here in depth. What follows is the absorption question underneath all of that: once something is swallowed, what actually happens to it, and why does the answer differ so much depending on the format it arrived in.
What is a whole food matrix, in plain terms?
Before going deeper into the mechanisms below, it is worth pausing on a term this article uses constantly: the food matrix itself. A whole food matrix is the natural, co-occurring structure of compounds in a food, as opposed to a single compound extracted and isolated on its own. Every whole food, a fruit, a vegetable, a grain, contains its nutrients embedded in a physical and chemical structure alongside fiber, water and its other naturally occurring compounds. That entire arrangement, in the ratios and physical form the plant produced, is the matrix. An isolate is a single component removed from that structure: ascorbic acid extracted and purified into a powder is an isolate, while the same vitamin C still inside the fruit, alongside everything else the fruit naturally contains, is part of a matrix. The chemical identity of the molecule does not change between the two; what changes is the surrounding structure it exists within. That distinction, structure intact versus structure stripped away, is the thread connecting every mechanism the rest of this article walks through.
What does "bioavailability" actually mean, precisely?
Bioavailability is a specific pharmacological and nutritional term, not a marketing adjective, and it is worth defining it exactly before using it loosely for the rest of this article. Bioavailability describes the fraction of an ingested compound that reaches systemic circulation in an active, usable form, expressed as a percentage of the total amount consumed. A nutrient with 100 percent bioavailability would mean every last molecule swallowed makes it into the bloodstream in a form the body can use. In practice, no nutrient behaves this way. Even water-soluble vitamins with famously high absorption rates, like vitamin C at typical dietary doses, are not absorbed at 100 percent, and many fat-soluble compounds, particularly carotenoids, are absorbed at rates that can run as low as single-digit percentages depending on the food matrix they arrive in and what else is eaten alongside them.
Bioavailability is not a single fixed number for a given compound. It changes based on the chemical form of the compound, the food matrix surrounding it, what else is consumed at the same meal, the health and digestive status of the person eating it, and even genetic variation between individuals in how efficiently they process certain nutrients. This is the central reason nutrition scientists resist blanket statements like "vitamin C is vitamin C no matter where it comes from." Chemically, that statement is often true, ascorbic acid is ascorbic acid whether synthesized industrially or extracted from a berry. Functionally, in terms of how much of it a specific person's body will actually take up and use after a specific meal, the statement can be misleading, because the matrix the ascorbic acid travels in changes the outcome.
Who actually established that food matrix changes absorption, and when?
The idea that "what a nutrient is eaten with" changes how much of it gets absorbed is not a recent wellness-industry talking point. It has a specific, decades-long research history built by named scientists working through careful, controlled feeding studies, long before it became a phrase used on supplement packaging.
One of the most influential frameworks in this field came from Christine West and Jacques Castenmiller, who in a widely cited 1998 paper in the International Journal for Vitamin and Nutrition Research introduced a mnemonic, SLAMENGHI, to organize the many variables that determine how much of a dietary carotenoid, like beta-carotene or lycopene, actually gets absorbed from a meal. SLAMENGHI stands for Species of carotenoid, molecular Linkage, Amount consumed in a meal, Matrix in which the carotenoid is incorporated, Effectors of absorption and bioconversion, Nutrient status of the host, Genetic factors, Host-related factors, and Interactions between these variables. West and Castenmiller's contribution was not discovering any single one of these factors in isolation, other researchers had already documented pieces of this picture, but organizing them into a single systematic framework that made clear bioavailability is never explained by one variable alone. Their "M," for matrix, sits at the center of this article's subject: the same carotenoid molecule, eaten in different food structures, produces measurably different absorption outcomes.
Building directly on that groundwork, Patrick Borel, a researcher based at INRA in France who has spent much of his career studying lipid-soluble micronutrient absorption, published a series of papers through the 2000s and 2010s establishing in detail how carotenoid and fat-soluble vitamin absorption depends on the presence of dietary lipids, the size and composition of the mixed micelles that form during digestion, and genetic variation in the transport proteins that move these compounds across the intestinal wall. Borel's 2003 review, and later collaborative work through the 2010s, helped establish that fat-soluble compounds are not passively absorbed the way a simple water-soluble molecule might be. They require a functioning digestive sequence involving bile, pancreatic lipase, and micelle formation, and if dietary fat is absent from a meal, that sequence does not proceed the same way, regardless of how much of the fat-soluble compound was technically swallowed.
On the food-matrix-and-processing side specifically, Sian Astley and colleagues, along with earlier foundational work by Christiane Rock, Alison Failla and Steven Schwartz through the 1990s, established that the physical disruption of plant cell walls, whether through cooking, chopping, juicing or pureeing, changes how accessible carotenoids and other compounds are for digestive uptake. Rock and Swendseid's 1992 study, for example, found that lightly cooked and pureed carrots produced higher measured beta-carotene absorption in human subjects than raw whole carrots, because cooking and mechanical disruption broke down the rigid cellulose cell walls that otherwise trap carotenoids inside intact plant cells. This body of work is part of why "the food matrix" is not a single fixed property of a plant. It is a property of the plant as prepared and eaten, which is a mechanically different question than whether a compound is present in the raw ingredient at all.
The omega point: why fat-soluble nutrients cannot skip the fat step
This is the single most concrete, well-documented mechanism in the entire bioavailability literature, and it deserves to be walked through slowly because it explains a specific practical failure mode that shows up constantly in supplement marketing. Carotenoids, which include beta-carotene, lycopene, lutein and zeaxanthin, are fat-soluble plant pigments. So are vitamins A, D, E and K. None of these compounds dissolve in water. For any of them to be absorbed from the gut into the bloodstream, they first have to be packaged, alongside dietary fat, into structures called mixed micelles inside the small intestine. Bile acids, released from the gallbladder in response to fat in a meal, emulsify dietary fat into small droplets. Pancreatic lipase then breaks that fat down, and the resulting fatty acid and monoglyceride fragments combine with bile acids and the fat-soluble compound of interest to form a micelle, a microscopic soluble carrier that can cross the intestinal lining. Without adequate dietary fat present at the same meal, this micelle-formation step is impaired, and a meaningful share of a fat-soluble compound simply passes through the gut without ever being packaged for absorption.
This is not a theoretical mechanism. It has been measured directly. A frequently cited study by Sherry Brown and colleagues, published in the American Journal of Clinical Nutrition in 2004, fed human subjects salads containing carotenoids alongside dressings with different fat content, avocado (high fat), reduced-fat dressing, or fat-free dressing, and measured blood carotenoid response afterward. The fat-free dressing condition produced dramatically lower measured absorption of the salad's carotenoids compared to the full-fat avocado condition, in the same meal, with the same vegetables, changing only the fat content eaten alongside them. This single study is one of the clearest human demonstrations that a fat-soluble nutrient's presence on a nutrition label does not predict how much of it gets absorbed; what it is eaten with does.
Sea buckthorn is a useful case study for this exact mechanism, because unlike most fruit, sea buckthorn pulp naturally contains its own fat: a native oil fraction, distinct from the seed oil, that carries much of the berry's carotenoid content. This is a structural, mechanical fact about the fruit's own pulp, not a claim about a measured absorption outcome in a specific study, since a head-to-head absorption trial comparing whole sea buckthorn puree against an isolated carotenoid capsule has not been run. What can be said accurately is this: a fat-soluble compound traveling inside a fruit that already carries its own fat fraction has, mechanically, the raw material present for micelle formation at the same eating occasion, without requiring the eater to remember to add a fat source separately, the way someone eating a fat-free carotenoid capsule or a dry vegetable would need to.
Synergy: when compounds that travel together help each other get used
Beyond the fat-solubility mechanism, a second and more subtle line of bioavailability research concerns synergy between co-occurring compounds, meaning cases where one plant compound measurably changes the absorption or stability of another compound present in the same food, in ways that would not happen if the two compounds were consumed separately.
The most extensively documented example involves vitamin C and iron. Non-heme iron, the form of iron found in plant foods, is notoriously poorly absorbed on its own, with absorption rates that can run below ten percent depending on the person and the meal. A body of research going back to work by Leif Hallberg and Lena Rossander-Hulten in Sweden through the 1980s established that vitamin C consumed at the same meal as non-heme iron significantly increases how much of that iron gets absorbed, apparently by converting iron to a more soluble, more readily absorbed chemical form in the acidic environment of the stomach and by counteracting inhibitory compounds like phytates that otherwise bind iron and block its uptake. This is a textbook example of one compound (vitamin C) changing the bioavailability of a completely different compound (iron), a synergy effect that would not occur if the two were eaten hours apart.
A second, more specific line of synergy research concerns flavonoids and vitamin C together. Joe Vinson and other researchers studying vitamin C stability and function through the 1990s and 2000s found that certain co-occurring flavonoids appear to protect vitamin C from oxidative degradation during digestion and may extend how long it remains active in circulation, compared to isolated ascorbic acid administered without any accompanying flavonoid content. The mechanism proposed is that flavonoids, many of which have their own antioxidant activity, can spare vitamin C from being oxidized before the body has a chance to use it, functioning somewhat like a bodyguard molecule traveling alongside the vitamin. This research area is still less definitively mapped than the fat-and-carotenoid mechanism described above, and reviewers in the field, including a 2007 review by Katherine Carr and colleagues, have been careful to note that flavonoid-vitamin C synergy findings vary by study design and are not universally reproduced at the same magnitude across every trial. The honest summary is that synergy between co-occurring compounds is a real, mechanistically plausible, and partially demonstrated phenomenon, documented most robustly for iron and vitamin C, and documented with reasonable but less uniform consistency for flavonoids and vitamin C, rather than a single settled rule that applies identically to every compound pair found together in a plant.
What this means structurally is straightforward: a whole fruit that naturally contains vitamin C alongside its own native flavonoid content is delivering, in one matrix, the two halves of a documented synergy relationship. An isolated ascorbic acid tablet, manufactured without any accompanying flavonoid content, is delivering only one half of that relationship, by definition, because isolating a compound is precisely the manufacturing step that removes what it used to travel with.
Why an isolated high dose does not behave like the same compound in food: the case study already written into the record
Nutrition science has one especially well-known, well-documented case where researchers tested directly whether isolating and concentrating a compound associated with a whole-food benefit would reproduce that benefit, and the answer, tested in large randomized controlled trials rather than assumed, was no. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study, known as the ATBC trial, published its primary results in 1994, and the Beta-Carotene and Retinol Efficacy Trial, known as CARET, published its primary results in 1996. Both trials tested high-dose isolated beta-carotene supplementation in at-risk smoking populations, following population research that had associated diets high in beta-carotene-rich fruits and vegetables with better outcomes. Both trials found that the isolated, concentrated supplement did not reproduce the protective association observed with whole-food intake, and in these specific high-risk populations, both trials were stopped early over safety signals.
This article is not the place to re-walk the full regulatory and historical context of those trials; that ground, including how the trials shaped the 1994 US and 2004 Canadian legal frameworks separating whole food from dietary supplement, is covered in depth elsewhere in the Journal. What belongs here, in a bioavailability-and-mechanism article, is the narrower, more technical question these trials raise: why would an isolated high dose of a compound behave differently in the body than the same compound eaten as part of a food, mechanistically, rather than just observationally?
Several mechanistic explanations have been proposed by researchers studying the ATBC and CARET results in the years since, and it is worth being precise that these are proposed mechanisms discussed in the literature, not a single proven causal pathway. One proposed mechanism involves pro-oxidant behavior at high concentration: beta-carotene, like many antioxidant compounds, appears to behave differently at very high, isolated concentrations than at the lower concentrations typically achieved through whole-food intake, with some research suggesting it can shift toward pro-oxidant activity under certain conditions, including in the oxygen-rich environment of a smoker's lungs, at concentrations far above what whole-food intake would ever produce. A second proposed mechanism concerns nutrient-nutrient interactions: isolated high-dose beta-carotene may interfere with the absorption or metabolism of other fat-soluble carotenoids and vitamin A precursors that would normally be present alongside it in a mixed whole-food diet, distorting a balance that whole-food intake does not disturb in the same way, because whole foods rarely deliver any single carotenoid at the isolated concentration achieved by a supplement. A third, more general explanation, consistent with everything else in this article, is simply that an isolated high dose is a fundamentally different exposure than the same compound diluted across a food matrix with fiber, water and dozens of co-occurring compounds moderating its absorption, its oxidative behavior and its interaction with everything else being digested at the same time. The honest position, and the position nutrition scientists studying this area generally hold, is that the ATBC and CARET results demonstrate isolation and concentration are not neutral manufacturing steps; they change the exposure in ways that can matter, and assuming an isolated compound will behave identically to its whole-food source is not a scientifically safe assumption to make by default.
First-pass metabolism, in plain terms
Bioavailability is not only about how much of a compound gets absorbed across the gut wall. It is also about how much of what gets absorbed survives the body's first attempt to process and eliminate it, a phenomenon called first-pass metabolism, and this step matters for essentially everything discussed in this article, regardless of format.
Here is the mechanical sequence. Once a compound is absorbed across the intestinal wall, it does not go directly into general circulation. Blood draining from the small intestine flows first through the portal vein directly into the liver, before reaching the rest of the body. The liver is the body's primary metabolic processing and detoxification organ, and it contains a dense battery of enzymes, prominently the cytochrome P450 family, along with conjugation enzymes that attach molecules like glucuronic acid or sulfate groups to compounds passing through, a process called glucuronidation and sulfation respectively. These enzymes evolved to identify foreign and potentially reactive compounds and modify them into forms that are more water-soluble and easier for the kidneys to excrete. Many plant compounds, including a large share of dietary flavonoids and polyphenols, get substantially modified by this first-pass process before they ever reach general circulation in their original chemical form. Some research suggests that for certain flavonoids, the majority of an ingested dose is converted into metabolite forms during first-pass processing, and it is these metabolites, not necessarily the original ingested molecule, that circulate through the rest of the body and produce whatever downstream effects occur.
This matters for the whole-food-versus-isolate question in two specific ways. First, first-pass metabolism happens regardless of the format a compound arrived in, whole food, capsule, liposomal formula or gummy; it is a property of the liver's processing of anything absorbed from the gut, not a property specific to any one delivery format. Second, and more relevant to synergy, some of the co-occurring compounds present in a whole food matrix have been studied for their effect on first-pass metabolic enzymes themselves. Certain flavonoids and other plant compounds can modestly influence the activity of specific cytochrome P450 enzymes and transport proteins involved in first-pass processing, a research area that has mostly been studied in the context of drug interactions, for example the well-documented case of grapefruit juice's flavonoid content altering the metabolism of certain medications by inhibiting a specific liver enzyme. The general principle this establishes, again without overstating it into a specific sea buckthorn claim, is that co-occurring compounds in a food matrix are not necessarily inert bystanders with respect to first-pass metabolism; some interact with the very enzyme systems that determine how much of an absorbed nutrient survives to reach general circulation in an active form.
Comparing formats: what actually happens to isolate pills, liposomal formulas, gummies, powders and whole food
With the underlying mechanisms established, it is worth walking through, format by format, what the bioavailability literature actually documents about each common delivery method, since these are the real choices a shopper is presented with on a shelf, and each has a genuinely different absorption profile rather than being interchangeable packaging for the same nutrition.
The isolate pill or tablet
A standard tablet or capsule delivers one or a few target compounds, concentrated and compressed or encapsulated, typically without the fat, fiber or co-occurring compound matrix that would accompany the same nutrient in whole food. For water-soluble compounds like isolated ascorbic acid, absorption can be reasonably efficient at typical doses, though some research suggests absorption efficiency for vitamin C specifically declines at very high single doses, a pattern documented by researchers including Balz Frei and colleagues studying vitamin C pharmacokinetics, meaning the body absorbs a smaller percentage of a very large single dose than it would of a smaller, more frequent dose. For fat-soluble compounds delivered in a dry tablet or standard capsule without co-formulated fat, the mechanism described above applies directly: without dietary fat present at the same eating occasion, micelle formation is impaired, and a meaningful share of the fat-soluble compound in the tablet may not be absorbed regardless of how much was technically swallowed. Tablets also carry a documented, if uncommon, disintegration risk, the "ghost tablet" phenomenon described in the opening of this article, where a compressed tablet's binding excipients fail to break down fully during transit, particularly in people with reduced stomach acid or fast gut transit time, meaning the tablet can pass through largely intact.
The liposomal formula
Liposomal delivery is a manufacturing approach that encapsulates a compound, most commonly vitamin C or certain other water-soluble nutrients, inside a microscopic lipid (fat) bubble called a liposome, designed to protect the compound during digestion and potentially improve its absorption by allowing it to be taken up through a different pathway than standard passive or transporter-mediated intestinal absorption. Some published research, including a small 2016 study by cardiologist Janet Davis and colleagues, has found measurably higher blood levels of vitamin C after liposomal-formulated doses compared to standard ascorbic acid tablets at an equivalent dose, particularly at higher doses where standard absorption efficiency declines. This is a genuinely interesting manufacturing innovation and a legitimate, evidence-supported approach for people specifically seeking a higher-dose vitamin C delivery method. It is worth being precise about what it is and is not: a liposomal formula is still an isolated compound, manufactured specifically to improve one narrow property (absorption efficiency of that one compound), and it does not restore the co-occurring flavonoid, fiber or whole-food compound matrix that this article has spent several sections establishing as functionally relevant. A liposomal vitamin C capsule and a whole fruit containing vitamin C are solving two different problems: one is optimizing delivery efficiency of a single isolated compound, the other is delivering the compound within its full natural matrix.
The gummy
Gummy-format supplements have grown substantially in the consumer market over the past decade, largely for palatability and compliance reasons rather than any documented absorption advantage. From a bioavailability standpoint, a gummy delivers an isolated or lightly formulated compound suspended in a sugar-and-gelatin or pectin matrix, and the research literature does not generally document a meaningful absorption advantage for the gummy format itself compared to a standard tablet or capsule containing the same compound at the same dose; the primary documented differences relate to consumer adherence (people are more likely to consistently take a product they find pleasant) and, separately, dosing consistency concerns that regulators in both the US and Canada have flagged, since gummies can be more prone to compound degradation from heat and moisture during storage, and are harder to manufacture with the same precise per-unit dosing consistency as a compressed tablet. A gummy is, mechanistically, still an isolate, sharing the same fat-solubility and matrix limitations described above for tablets, formulated for taste and habit rather than for absorption physiology.
The powder
Powdered supplement formats span a wide range, from freeze-dried whole-food powders that retain a meaningful share of the original fruit's fiber and compound matrix, to standardized extract powders built around one or a few target compounds at a stated concentration percentage, the same isolate logic as a tablet in a different physical form. The bioavailability profile of a powder therefore depends entirely on which of these two categories it falls into, and this is one of the more commonly misunderstood distinctions on a supplement shelf, since both types are sold as "powder" without that word telling a shopper which category applies. A freeze-dried whole-berry powder, properly processed, retains most of the plant's original compound matrix and a meaningful share of its fiber, differing from a fresh whole-food puree primarily in water content rather than in matrix composition. A standardized extract powder, by contrast, has already had the isolation and concentration step applied, and shares the same absorption considerations as an isolate tablet, regardless of its powder format.
Whole food
Whole food, meaning the plant material itself with its fiber, water content and full compound matrix intact, is the format every mechanism discussed in this article converges on. Fat-soluble compounds traveling with the plant's own native fat fraction have the raw material present for micelle formation without requiring a separately remembered fat pairing. Compounds documented to interact synergistically, such as vitamin C and co-occurring flavonoids, or vitamin C and iron in a mixed meal, are present together rather than isolated apart. The concentration of any single compound remains within the range naturally produced by the plant, rather than elevated to the isolated, high-dose concentrations that the ATBC and CARET research suggests can behave differently in the body than food-level exposure. None of this is a claim that whole food achieves a specific measured absorption percentage superior to every isolate for every compound in a head-to-head trial; as this article has repeated throughout, that specific comparative research has not been run for most whole foods, sea buckthorn included. It is, instead, a description of which established absorption mechanisms whole food structurally satisfies by default, without requiring the eater to engineer a fat pairing, a synergy pairing or a moderated dose the way choosing among isolated formats would require.
| Format | What it structurally delivers | Known absorption consideration |
|---|---|---|
| Isolate tablet or capsule | One or a few target compounds, concentrated, generally without co-formulated fat or matrix compounds | Fat-soluble compounds need dietary fat present at the same meal for micelle formation; disintegration failure ("ghost tablets") is a documented, if uncommon, risk |
| Liposomal formula | An isolated compound (commonly vitamin C) encapsulated in a lipid shell to alter its absorption pathway | Documented higher blood levels versus standard tablets at equivalent high doses in some published research; still an isolate without the whole-food compound matrix |
| Gummy | An isolated or lightly formulated compound in a sugar-gelatin or pectin matrix | No documented absorption advantage over an equivalent-dose tablet; primary benefit is palatability and adherence, not bioavailability; storage stability is a known manufacturing concern |
| Standardized extract powder | One or a few target compounds concentrated to a stated percentage, in powder form | Shares the same isolate absorption considerations as a tablet, regardless of powder format |
| Freeze-dried whole-food powder | Most of the plant's original compound matrix and a meaningful share of fiber, with water content removed | Closer to whole-food matrix behavior than a standardized extract; processing care affects how much heat- and moisture-sensitive compound content survives drying |
| Whole-food puree | The full compound matrix, native fat fraction, fiber and water content, minimally processed | Structurally satisfies the fat-pairing and synergy mechanisms documented above by default, without requiring the eater to combine separate products |
What this means, practically, for choosing between formats
Pulling the mechanisms above together into a single decision framework is more useful than treating each one as a separate trivia fact. The question a shopper should actually be asking is not "which format is best," a question with no single correct answer, but "which format structurally supports the specific absorption mechanism that matters for the specific compound I am trying to get." For a fat-soluble compound like a carotenoid or vitamin D, the fat-pairing mechanism is the dominant variable, which means an isolate taken on an empty stomach without any accompanying fat is working against the very mechanism that determines whether it gets absorbed at all, regardless of the number printed on the label. For a compound with a documented synergy partner, vitamin C alongside flavonoids, or non-heme iron alongside vitamin C, an isolate strips out exactly the partner compound the research shows matters, while a whole food retains that pairing by construction rather than by any deliberate choice on the eater's part. For a compound where a specific, precisely measured high dose is the actual clinical or personal goal, a liposomal or standardized isolate format has real, documented value that a whole food cannot match, because whole food's compound concentrations are bounded by what the plant naturally produces, while an isolate can be concentrated well past that ceiling.
None of this is an argument that a shopper needs to become a personal pharmacologist before choosing a vitamin. It is an argument for a much simpler habit: before assuming a product's absorption profile from its marketing language, check what the mechanism research above actually requires, whether that is a fat pairing, a synergy partner, or a moderated dose, and then check whether the specific product in hand structurally provides that requirement or requires the eater to supply it separately. A capsule that says "high potency" is describing a dose, not an absorption outcome, and the gap between those two words is the entire subject of this article.
What the fiber matrix does to the pace of absorption
One further mechanism deserves its own explanation, separate from fat-solubility and compound synergy: the effect of fiber and structural plant material on the speed and pattern of nutrient release during digestion. Whole food generally reaches the small intestine more slowly and releases its contents over a longer window than an isolated compound in a capsule, which the digestive system encounters essentially all at once, without any surrounding structural matrix to moderate the release. This is one of the most thoroughly studied general principles in digestive physiology, most extensively documented in glycemic response research, where whole fruit, fruit juice and an isolated sugar solution produce measurably different, and measurably slower in the case of whole fruit, blood sugar response curves, despite sometimes containing a comparable total sugar quantity. David Jenkins, the researcher who developed the glycemic index concept in the late 1970s and early 1980s at the University of Toronto, and whose foundational papers established much of this comparative methodology, showed repeatedly across different whole foods that fiber and food structure change the rate of nutrient encounter, independent of the underlying compound's chemical identity.
The same general principle, that structural matrix moderates release pace, is a reasonable, evidence-consistent expectation to extend to other compounds beyond sugar, though it is important to be precise that this has been most rigorously proven for glycemic response specifically, and applying it to every nutrient in every whole food as a blanket, universally-measured rule would overstate what the literature directly shows. What can be said accurately is that a fiber-and-water matrix changes the physical environment a nutrient is released into during digestion, and an isolated compound swallowed without that matrix does not have the same moderating structure present, which is a mechanical fact about digestion rather than a specific claim about any one product's measured outcome.
Myth vs fact: absorption and bioavailability
| Claim commonly repeated | What the evidence actually supports |
|---|---|
| "Bioavailable" is just a buzzword with no measurable definition | False. Bioavailability is a specific, measurable pharmacological term describing the percentage of an ingested compound that reaches systemic circulation in an active form, quantified in controlled studies using blood sampling over time. |
| Vitamin C is vitamin C, absorption does not depend on the source | Chemically, ascorbic acid is identical regardless of source. Functionally, absorption efficiency can be affected by dose size and by the presence of co-occurring compounds like flavonoids, which some research links to reduced oxidative loss of vitamin C during digestion. |
| A fat-soluble vitamin or carotenoid in a capsule is absorbed the same whether or not you eat fat with it | Not supported. Carotenoid and fat-soluble vitamin absorption depends on mixed micelle formation, which requires dietary fat present at the same meal; documented research (including the 2004 Brown et al. salad-dressing study) shows measurably lower absorption without it. |
| A higher isolated dose always delivers more usable nutrient than a lower whole-food amount | Not established as a general rule, and directly contradicted for beta-carotene by the ATBC and CARET trials, and for vitamin C by research showing declining absorption efficiency at very high single doses. |
| Liposomal and gummy formats are absorption upgrades over any standard capsule | Liposomal formulation has some documented absorption benefit specifically for high-dose vitamin C versus a standard tablet. Gummies do not have documented absorption advantages over an equivalent-dose tablet; their main benefit is palatability, not bioavailability. |
| "Whole food always absorbs better than any supplement, for every nutrient, in every case" | Too broad to state as fact. Specific documented mechanisms (fat-carotenoid pairing, vitamin C-iron synergy, fiber-moderated release pace) support a food-matrix advantage in particular, named cases; a universal claim covering every compound and every format has not been established in head-to-head research. |
Where does Human Renaissance fit?
Human Renaissance is the only sea buckthorn puree in the world sold in a single-serve pouch. Human Renaissance sea buckthorn puree contains 190+ naturally occurring compounds, omega 3, 6, 7 and 9, 201 mg of vitamin C per pouch, 0 g sugar and 5,640 hand-picked berries per box. It is pressed from the whole berry, native oil fraction intact, nothing extracted and nothing isolated out, which places it structurally in the whole-food category this article has described as satisfying the fat-pairing and synergy mechanisms above by default. This is a description of what the product physically is and how it is made, not a claim that a specific measured absorption percentage has been tested for this product against any capsule in a head-to-head trial; that specific study has not been run for sea buckthorn puree, and this article has been careful throughout to separate documented mechanism from an unproven specific-product outcome claim. For readers who want the full nutrient breakdown behind these numbers, see the sea buckthorn nutrition facts page, and for the definitional and regulatory whole-food-versus-supplement question this article deliberately did not re-cover, see whole food, not supplement.
How does this play out across different life stages, from an absorption standpoint specifically?
Digestive physiology changes across adult life in ways that specifically affect nutrient absorption, separate from the general dietary-pattern and polypharmacy considerations that apply to supplement decisions broadly. It is worth walking through what changes, mechanically, by decade, without turning any of this into individual guidance, since any specific absorption concern belongs in a conversation with a qualified healthcare provider who knows a person's actual digestive history.
In the 30s, digestive function is generally at or near its lifetime baseline for most healthy adults, meaning stomach acid production, pancreatic enzyme output, and bile production supporting fat-soluble nutrient absorption are typically functioning at full capacity, absent a specific diagnosed condition. This is the life stage where the format-choice question is most purely about matching format to goal, since baseline absorption machinery is generally not the limiting factor for most people. Around 45 and beyond, some research has documented a gradual decline in stomach acid production in a subset of the population, a condition called hypochlorhydria when clinically significant, which can affect the breakdown and release of certain nutrients from food and from tablet or capsule matrices alike, since stomach acid plays a role both in disintegrating some tablet formulations and in liberating certain minerals and compounds from a food matrix for further digestion downstream. This is also the life stage where tablet disintegration failures, the "ghost tablet" phenomenon described in the opening of this article, become somewhat more commonly documented in case literature, plausibly related to reduced stomach acid slowing the breakdown process a tablet's binding excipients depend on. For adults 60 and older, research has documented further, more consistent declines in several digestive functions relevant to absorption: reduced stomach acid is more prevalent, pancreatic enzyme output can decline, and bile production supporting fat-soluble nutrient absorption, the exact mechanism this article has spent several sections explaining, can also be affected by age-related changes in liver and gallbladder function. None of this is a specific claim about what any individual should do differently; it is a description of general population research on how digestive physiology changes with age, and the practical response to any of it, format choice included, is an individual question for a healthcare provider who can assess an actual person's digestive status rather than a general age bracket.
A practical protocol for evaluating any product's absorption claims
- Identify whether the product is an isolate or a whole food. Check the ingredient list for a named whole plant versus a standardized extract percentage or a bare compound name; this determines which of the mechanisms in this article even apply.
- If it is a fat-soluble compound in isolate form, check whether it is co-formulated with fat, or plan to eat it with a meal containing dietary fat. Carotenoids, and vitamins A, D, E and K, will not form absorption-ready micelles without dietary fat present at the same eating occasion, regardless of the dose on the label.
- Look for what the compound is traveling with, not just the compound itself. A vitamin C source accompanied by its native flavonoid content, as in whole fruit, is delivering a documented synergy pairing; an isolated ascorbic acid tablet is not, by definition, since isolation is the manufacturing step that removes what a compound used to travel with.
- Do not assume a higher isolated dose is automatically a bigger absorption win. Both vitamin C and beta-carotene research show that very high isolated doses can behave differently, sometimes with lower absorption efficiency and, in beta-carotene's case, with a different physiological effect entirely, than the same compound delivered at food-level concentrations.
- Match the format to the actual goal. A liposomal formula makes sense when a specific, measured high dose of one compound is the goal and standard-tablet absorption efficiency is a documented limitation for that goal. A whole-food source makes sense when retaining the full matrix, fat pairing and synergy compounds included, is the goal. Neither is a universal upgrade over the other; they solve different problems.
- Ask what has actually been measured, versus assumed. A product's marketing describing itself as "highly bioavailable" should be checked against whether any study actually measured blood levels after ingestion, or whether the claim is an inference from the product's format alone.
Glossary
| Term | What it means here |
|---|---|
| Bioavailability | The measurable percentage of an ingested compound that reaches systemic circulation in an active, usable form. |
| Food matrix | The complete physical and chemical structure of a food as eaten, including fiber, water, fat content and the full set of co-occurring compounds, which together influence how the food's nutrients are digested and absorbed. |
| Mixed micelle | A microscopic soluble carrier formed in the small intestine from bile acids, digested fat fragments and fat-soluble compounds, required for fat-soluble nutrients to cross the intestinal wall. |
| SLAMENGHI | A mnemonic introduced by West and Castenmiller in 1998 organizing the variables that determine carotenoid bioavailability: Species, molecular Linkage, Amount, Matrix, Effectors, Nutrient status, Genetic factors, Host-related factors, and Interactions. |
| Synergy (nutrient synergy) | A documented case where one compound measurably improves the absorption or stability of a different compound consumed at the same time, such as vitamin C improving non-heme iron absorption. |
| First-pass metabolism | The liver's initial processing of compounds absorbed from the gut, before they reach general circulation, which can substantially modify or reduce the active form of many plant compounds. |
| Glucuronidation and sulfation | Liver enzyme processes that attach molecules to compounds passing through first-pass metabolism, generally making them more water-soluble and easier to excrete, often reducing the amount of the original compound reaching circulation intact. |
| ATBC and CARET trials | Two major 1990s randomized controlled trials testing isolated high-dose beta-carotene supplementation, both finding it did not reproduce the protective association seen with whole-food beta-carotene intake in at-risk populations, and both stopped early over safety signals. |
| Liposomal delivery | A manufacturing method encapsulating a compound, commonly vitamin C, inside a microscopic lipid shell, documented in some research to improve absorption at high doses compared to a standard tablet. |
| Ghost tablet | The informal term for a tablet or capsule shell that fails to disintegrate fully during digestion and is recovered largely intact, more commonly documented in people with reduced stomach acid or fast gut transit. |
What this did not establish, in one line
Documented absorption mechanisms, fat pairing for carotenoids, vitamin C and iron synergy, fiber-moderated release pace, are real and separately established in the research cited above. No study cited here tested whole sea buckthorn puree head-to-head against an isolated sea buckthorn capsule for a measured absorption outcome, and this article does not claim that comparison has been run.
A closing summary, for readers who only want the practical answer
Absorption is not a footnote to nutrition, it is the entire point of eating anything at all, and the format a nutrient arrives in changes the outcome in specific, documented, mechanistic ways. Fat-soluble compounds like carotenoids require dietary fat at the same meal to form the mixed micelles that let them cross into the bloodstream, a mechanism established by researchers including Christine West, Jacques Castenmiller and Patrick Borel and demonstrated directly in controlled feeding studies. Certain compounds measurably help each other get absorbed when consumed together, most clearly documented for vitamin C and non-heme iron. Isolating and concentrating a single compound out of its whole-food context is not a neutral step; the ATBC and CARET beta-carotene trials remain the clearest large-scale demonstration that an isolated high dose can behave differently in the body than the same compound eaten as food. And everything absorbed still has to survive first-pass metabolism in the liver before it reaches the rest of the body, regardless of what format it started in. None of this makes any single format universally correct. A liposomal formula, a standardized extract, and a whole-food puree are each solving a different problem, and the informed choice is the one that matches the actual goal to the format that structurally supports it, checked against what the label and the ingredient list actually say was done to the material, rather than against what the packaging implies.
Frequently asked questions
What does bioavailability actually mean, in one sentence?
It is the measurable percentage of a compound you swallow that actually reaches your bloodstream in an active, usable form, rather than passing through unabsorbed or being broken down before it can be used.
Why do carotenoids need fat to be absorbed?
Carotenoids are fat-soluble and must be packaged into mixed micelles, structures built from bile acids and digested dietary fat, in order to cross the intestinal wall. Without dietary fat present at the same meal, this packaging step is impaired, documented directly in controlled feeding studies including a 2004 salad-dressing study by Sherry Brown and colleagues.
Who established the framework for how food matrix affects carotenoid absorption?
Christine West and Jacques Castenmiller published the SLAMENGHI framework in 1998, organizing the variables, including food matrix, that determine carotenoid bioavailability. Patrick Borel's later research further detailed the mixed-micelle mechanism specifically.
What is nutrient synergy, and is it real?
It is a documented case where one compound improves the absorption or stability of a different compound eaten at the same time. The clearest, most established example is vitamin C improving non-heme iron absorption, research going back to Leif Hallberg and Lena Rossander-Hulten's work in the 1980s. Flavonoid-vitamin C synergy is also documented, though with somewhat less consistent findings across different studies.
What did the ATBC and CARET trials actually find, from an absorption and mechanism standpoint?
Both trials tested high-dose isolated beta-carotene supplementation and found it did not reproduce the protective association seen with whole-food beta-carotene intake in at-risk smoking populations, and were stopped early over safety signals. Proposed mechanisms discussed in the literature include pro-oxidant behavior at very high isolated concentrations and interference with other fat-soluble compound absorption, though these remain proposed explanations rather than a single proven pathway.
What is first-pass metabolism?
It is the liver's initial processing of anything absorbed from the gut, before it reaches general circulation. Liver enzymes, including the cytochrome P450 family and conjugation enzymes, substantially modify many plant compounds during this step, meaning what circulates through the rest of the body is often a metabolite, not the original ingested molecule.
Does first-pass metabolism happen no matter what format I take a nutrient in?
Yes. It is a property of how the liver processes anything absorbed from the intestine, not something specific to capsules, gummies, or any other single format.
Is a liposomal vitamin C supplement better absorbed than a regular tablet?
Some published research, including a small 2016 study, found higher blood levels after liposomal-formulated high doses compared to standard tablets at an equivalent dose. It remains an isolated compound, without the accompanying flavonoid or fiber matrix present in whole fruit.
Are gummy vitamins absorbed better than pills?
The research literature does not generally document an absorption advantage for gummies over an equivalent-dose tablet or capsule. Their documented benefit is palatability and consumer adherence, not measured bioavailability, and they carry their own documented storage-stability concerns.
What is a "ghost tablet," and how common is it?
It is the informal term for a tablet or capsule shell recovered largely intact in stool, meaning it failed to fully disintegrate during digestion. It is documented in case literature more often in people with reduced stomach acid or fast gut transit, and is not considered a common outcome for most healthy adults, but it is a real, published phenomenon.
Does whole food absorb better than a supplement for every nutrient?
Not as a universal claim. Specific, well-documented mechanisms, fat-carotenoid pairing, vitamin C-iron synergy, and fiber-moderated release pace, support a food-matrix advantage in particular, named cases. A blanket claim that whole food outperforms every isolate for every compound has not been established in head-to-head research and this article does not make that claim.
Does eating fat with a fat-soluble vitamin capsule fix the absorption problem?
Taking a fat-soluble supplement with a meal containing dietary fat is a reasonable, evidence-consistent practice supported by the mechanism described in this article. It does not restore the additional co-occurring compounds present in a whole-food source of the same nutrient; it addresses the fat-pairing mechanism specifically, not the broader compound-matrix question.
Why does sea buckthorn puree get discussed as a case study for the fat-solubility mechanism?
Because sea buckthorn pulp naturally contains its own native oil fraction alongside its carotenoid content, meaning the fat needed for the micelle-formation mechanism described in this article is structurally present in the same food, rather than requiring a separately remembered pairing. This is a description of the fruit's composition, not a measured absorption-outcome claim, since that specific comparative study has not been run for this fruit.
Does age change how well nutrients are absorbed?
Research has documented general population trends toward reduced stomach acid, altered pancreatic enzyme output and changes in bile production with age, particularly from the mid-40s onward and more consistently past 60, all of which can affect nutrient absorption from both food and supplement sources. Any specific individual concern belongs in a conversation with a healthcare provider familiar with that person's digestive history.
Is a higher dose always better for absorption?
No. Vitamin C absorption efficiency has been shown to decline at very high single doses, and the ATBC and CARET trials found that isolated high-dose beta-carotene did not reproduce whole-food-level outcomes. Dose and absorption efficiency are not the same thing, and a bigger number on a label does not guarantee more of the compound reaches circulation.
What should I actually check on a label if I care about absorption?
Whether the product is a whole food or an isolate, whether a fat-soluble compound is co-formulated with fat or needs to be paired with a meal that has fat, whether the compound is accompanied by documented synergy partners like flavonoids, and whether any bioavailability claim on the packaging is backed by an actual measured study rather than inferred from the format alone.
Does freeze-dried powder absorb the same as fresh whole-food puree?
Freeze-drying primarily removes water content while generally retaining most of a food's original compound matrix and a meaningful share of its fiber, placing it closer to whole-food matrix behavior than a standardized extract. It is still a different process from pressing fresh whole fruit, and processing care affects how much heat- and moisture-sensitive compound content survives the drying step.
Is this article saying supplements do not work?
No. Isolated formats, including liposomal delivery, have real, documented uses, particularly when a specific, measured single-compound dose is the actual goal. This article's point is that whole food and isolated formats are structurally different products with different, separately documented absorption mechanisms, not that one category is universally superior or that isolated compounds are ineffective.
Why does vitamin C need flavonoids to be more stable, mechanically?
Proposed research suggests certain flavonoids have their own antioxidant activity that can protect vitamin C from being oxidized and degraded during digestion, effectively sparing it so more remains in an active form. This research area is real but less uniformly consistent across studies than the fat-carotenoid mechanism, and should be described with that caveat rather than as a fully settled finding.
Does cooking or processing a fruit change its bioavailability?
Yes, documented directly in research including Rock and Swendseid's 1992 carrot study, which found that cooking and mechanical disruption of plant cell walls increased measured beta-carotene absorption compared to raw whole carrots, by making the compound more physically accessible to digestive processes.
Does a whole food matrix mean the food has to be unprocessed?
Not exactly. A puree can still preserve the matrix if the whole fruit, including its natural array of compounds, goes into the final product together, rather than a single compound being extracted and everything else discarded. The relevant line is not processed versus unprocessed; it is whether the food's natural co-occurring structure stays intact, or whether one piece has been pulled out and isolated from the rest.
Why do so many products list one nutrient instead of the whole matrix?
It is simpler to market and standardize a single measurable compound. Describing a full matrix requires naming the whole food itself, which is a different kind of claim than stating one isolated ingredient's dose.
Where can I read more about the whole-food-versus-supplement regulatory and definitional question separate from absorption mechanism?
That ground, including the 1994 US and 2004 Canadian legal frameworks separating whole food from dietary supplement, and the fuller regulatory history behind the ATBC and CARET trials, is covered in the Journal's dedicated piece on whole food, not supplement, which this article intentionally did not repeat.
The pouch is available at humanrenaissance.ca/products/sea-buckthorn-puree, whole berry, native oil fraction intact, pressed and sealed rather than isolated apart. Related reading: sea buckthorn nutrition facts and pulp oil versus seed oil.




0 Comments